HER2-Positive Metastatic Breast Cancer: Current Status and Promising Agents on the Horizon

Download All
Review the latest data and expert guidance to enhance treatment of your patients with HER2-positive MBC! This comprehensive program features a text-based educational module with downloadable slides and focused clinical commentaries on recent advances and emerging research.
Adam M. Brufsky, MD, PhD


Get up to date on optimal management of HER2-positive MBC with these expert-authored slides covering the latest data on HER2-directed TKIs, antibody–drug conjugates, and re-engineered antibodies.

Adam M. Brufsky, MD, PhD Released: April 13, 2020
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Daiichi Sankyo, Inc.
Puma Biotechnology, Inc.
Seattle Genetics

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings